CClinicalTrials.gg
Enrolling by invitationNCT05985876KULEA-NETUpdated Aug 14, 2023

KULEA-NET: A Mobile Application for African American/Black Mothers to Promote Exclusive and Continuous Breastfeeding

A Phase 2 interventional study of KULEA-NET application and Control Group: Usual Care in Breastfeeding and Exclusive Breastfeeding, sponsored by Benten Technologies, Inc.. Enrolling by invitation at 3 sites in United States. Open to female participants aged 18 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-14.

Sponsored by Benten Technologies, Inc. · Phase 2, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 5 months ago, but the record still lists the study as enrolling by invitation.
Phase
Phase 2
Study type
Interventional
Enrollment
523
Allocation
Randomized
Ages
18 Years to 44 Years
Sex
Female
01

Study summary

KULEA-NET is a mHealth intervention that will improve knowledge, self-efficacy, and intentions related to exclusive breastfeeding (EBF). These factors have been demonstrated to have a positive influence on breastfeeding (BF) initiation and duration among African American/Black (AA/B) mothers. In the long term, KULEA-NET has great potential to achieve increased BF initiation and EBF rates among AA/B mothers and as a result, improved maternal and infant health outcomes.

Read the detailed description

Failure to initiate breastfeeding (BF) and exclusively breastfeed (EBF) for the recommended 6-month duration, can result in long-term morbidity among both mothers and their infants. African Americans/Blacks (AA/B) have the lowest BF initiation and EBF rates among all racial ethnicities in the US. AA/B infants have disproportionately high rates of mortality, and children have a high incidence of asthma and sudden infant death syndrome (SIDS) while AA/B mothers are at high risk for chronic illnesses like obesity, diabetes, and cardiovascular diseases. These health disparities cost the US more than $9.1 billion in medical treatment annually but can be reduced by increasing EBF rates. However, AA/B women experience barriers on multiple levels to initiating, continuing BF, and maintaining EBF (either by discontinuing BF or introducing supplements BF with other foods). With high rates of smartphone ownership and consumption of digital content in AA/B women, the proposed mHealth intervention has great potential to increase BF initiation and maintain EBF among AA/B women and has demonstrated feasibility (user satisfaction and use) in our prior completed feasibility study. The proposed SBIR Direct Phase II application, Knowledge and Usage of Lactation using Education and Advice from Support Network (KULEA-NET) addresses an unmet need for an evidence-based mobile app, providing comprehensive BF support and addresses the interrelated and complex BF barriers AA/B mothers experience across the socio-ecological layers.

KULEA-NET will provide comprehensive BF support to nurture and support AA/B women in BF initiation and EBF, and include the following innovative features: a) Social marketing and health branding to promote EBF as a socially desirable behavior; b) Micro-learning educational content to improve the acquisition of knowledge and skills related to EBF; c) Support network communication tools leveraging asynchronous communication that allow mothers to communicate with her BF supporters, peers, and lactation professional supports; d) Context-aware delivery framework that will capitalize on user information such as date of delivery, feeding, and diaper log data, and location variables to provide timely feedback, content, and guidance; and e) a Virtual community support network bringing together AA/B mothers and their spouse/family members, and fostering a community of mutual support.

The hypothesize of KULEA-NET is to improve knowledge, BF self-efficacy, and intentions to BF, and ultimately achieve increased BF initiation, BF duration, and EBF rates at 6 months among AA/B mothers and, as a result, improved maternal and infant health outcomes.

02

Conditions studied

  • Breastfeeding
  • Exclusive Breastfeeding
03

In context

Lead sponsor

Benten Technologies, Inc. is the lead sponsor of 4 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • African American/Black Ethnicity
  • Speak and understand English,
  • Between the ages of 18-44 years,
  • Intention to continue BF after discharge from the hospital
  • Willingly provide written informed consent
  • Own a smartphone (either iOS or Android)
  • Have access to the internet through their smartphone

Exclusion criteria

Exclusion Criteria:

  • An infant born with cleft lip/palate, congenital heart defects, Down Syndrome, neural tube defects, or other conditions that require admission to a NICU or interfere with BF
  • Human immunodeficiency virus (HIV)
  • Taking antiretroviral medication or chemotherapy agents
  • Untreated, active tuberculosis
  • T-Cell lymphotropic virus type I or type II
  • Illicit drug use
  • Receiving radiation therapy
  • Exposed to anthrax
  • Undergone breast surgery
  • Active hepatitis B or C
  • Any prescription drug use incompatible with lactation
05

Study design

Phase
Phase 2
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
523 participants (estimated)

Study arms

  • Experimental
    KULEA-NET application

    Participants using the KULEA-NET application in addition to the usual care

    Behavioral: KULEA-NET application

  • Experimental
    Control Group: Usual Care

    Control participants will receive usual care i.e. standard obstetrical care at MWHC and Mamatoto Village and will receive the standard Babyscripts app only without the KULEA-NET tile.

    Behavioral: Control Group: Usual Care

Interventions

  • BehavioralKULEA-NET application

    African American/Black (AA/B) women recruited at 3 distinct stages of pregnancy - i.e. 1) 29 to 34 weeks gestational age, 2) 35 to 40 weeks gestational age, and 3)immediately post-partum, will be assigned to the intervention group and start using the KULEA-NET platform. Women in the intervention arm #1 will use KULEA-NET for a total duration of approximately 9 months (3 months prenatal and 6 months post-partum; women in the intervention arm #2 will use KULEA-NET for a total duration of approximately 7 months (1 month prenatal and 6 months post-partum); and women in the intervention arm #3 will use KULEA-NET for a total duration of approximately 6 months (only post-partum). Each woman will have access to all components of the KULEA-NET platform: the text messages, knowledge base, 3 different types of videos, and breastfeeding-friendly spaces and breastfeeding classes near them.

  • BehavioralControl Group: Usual Care

    Control participants will receive usual care i.e. standard obstetrical care at MWHC and Mamatoto Village and will receive standard Babyscripts app only without the KULEA-NET tile. Information from the ACOG about the maternal and infant health benefits of breastfeeding will also be provided (e.g., they will get pamphlets on the importance of breastfeeding as well as lactation consultation).

06

What researchers measure

Primary outcomes

  1. Change of exclusive breastfeeding (EBF) rates

    We will assess if participants are breastfeeding exclusively through self-reported information and corroborate with data entered in the feeding and diaper logs. We will record information on EBF at 4 weeks, and 24 weeks follow-up among women in the intervention arm #1. We will record information on EBF at 4 weeks, and 24 weeks follow-up among women in the intervention arm #2. We will record information on EBF at baseline, 4 weeks, and 24 weeks follow-up among women in the intervention arm #3.

    Time frame: Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up

Secondary outcomes

  1. Change of any breastfeeding (BF) rates

    We will assess if participants are breastfeeding through self-reported information and corroborate with data entered in the feeding and diaper logs. We will record information on BF at 4 weeks, and 24 weeks follow-up among women in the intervention arm #1. We will record information on BF at 4 weeks, and 24 weeks follow-up among women in the intervention arm #2. We will record information on EBF at baseline, 4 weeks, and 24 weeks follow-up among women in the intervention arm #3.

    Time frame: Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up

  2. Change of breastfeeding initiation rates

    We will assess if participants are initiated breastfeeding through self-reported information and corroborate with data entered in the feeding and diaper logs. We will record information on BF initiation at baseline, 4 weeks, and 24 weeks follow-up among women in the intervention arm.

    Time frame: Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up

Other outcomes

  1. Change of breastfeeding attitudes

    Iowa Infant Feeding Attitude Scale (IIFAS)

    Time frame: Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up

  2. Change of intention to breastfeed

    Infant Feeding Intentions (IFI) Scale

    Time frame: Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up

  3. Change of breastfeeding self-efficacy

    BF Self-Efficacy Scale Short Form (BSES-SF)

    Time frame: Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up

  4. Change of perceived social support and social self-efficacy

    Interpersonal Support Evaluation List (ISEL)

    Time frame: Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up

  5. Usability

    System Usability Scale (SUS)survey will be used to assess usability of the KULEA-NET app

    Time frame: Week 24 postpartum

  6. Engagement

    Brand Equity Scale to measure engagement with the app

    Time frame: Week 24 postpartum

  7. Change of knowledge and beliefs about breastfeeding

    Custom survey, based in part on an instrument developed by Dr. Evans and colleagues to evaluate the KULEA-NET intervention (GWU IRB approval # 111047), will be used to collect self-reported knowledge and attitudes related to breastfeeding.

    Time frame: Baseline, week 4 postpartum follow-up and week 24 postpartum follow-up

07

Study locations

3 sites
  • Mamatoto Village
    Washington, District of Columbia 20019-3739, United States
  • The George Washington University
    Washington, District of Columbia 20052-0042, United States
  • Medstar Health Research Institute
    Hyattsville, Maryland 20782, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 14, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05985876
Lead sponsor
Benten Technologies, Inc.
Collaborators
George Washington University, Medstar Health Research Institute, National Institute on Minority Health and Health Disparities (NIMHD)
Responsible party
Tony Ma (Project Director or Principal Investigator, Benten Technologies, Inc.) — Principal investigator
First posted
Aug 14, 2023
Start date
Nov 1, 2023 (estimated)
Primary completion
Apr 30, 2024 (estimated)
Completion
May 30, 2024 (estimated)
Last update
Aug 14, 2023

Study contacts

Tony Ma, MS
principal investigator · Benten Technologies
Doug Evans, PhD
principal investigator · George Washington University
Loral Patchen, PhD
principal investigator · Medstar Research Health Institute

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion